Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Short term Debt (2018 - 2025)

Veracyte's Short term Debt history spans 9 years, with the latest figure at $1.3 million for Q4 2025.

  • For Q4 2025, Short term Debt fell 92.16% year-over-year to $1.3 million; the TTM value through Dec 2025 reached $1.3 million, down 92.16%, while the annual FY2025 figure was $1.3 million, 92.16% down from the prior year.
  • Short term Debt for Q4 2025 was $1.3 million at Veracyte, down from $13.6 million in the prior quarter.
  • Across five years, Short term Debt topped out at $17.0 million in Q4 2024 and bottomed at $1.1 million in Q1 2022.
  • The 5-year median for Short term Debt is $3.4 million (2021), against an average of $5.9 million.
  • The largest annual shift saw Short term Debt soared 539.1% in 2024 before it plummeted 92.16% in 2025.
  • A 5-year view of Short term Debt shows it stood at $2.7 million in 2021, then skyrocketed by 125.95% to $6.1 million in 2022, then crashed by 56.16% to $2.7 million in 2023, then skyrocketed by 539.1% to $17.0 million in 2024, then crashed by 92.16% to $1.3 million in 2025.
  • Per Business Quant, the three most recent readings for VCYT's Short term Debt are $1.3 million (Q4 2025), $13.6 million (Q3 2025), and $13.4 million (Q2 2025).